Abstract. The recent study of the traditional medicines in China has given us confidence that what was recorded in Chinese ancient medical literature through empirical observations is indeed still coincident with modem chemistry, pharmacology and medicine. An antimalarial drug, artemether, and an acetylcholinesterase inhibitor, huperzine A, are exemplified.
INTRODUCTION
Plants were mankind's first medicines. From ancient to modern history, traditional plant-based medicines have played an important role in health care. In spite of the great advances of modem scientific medicine, traditional medicine is still the primary form of healing methods readily available to the majority of the people in the developing countries. In fact many of today's popular drugs have their origins in traditional medicines, and even in the United States, over half of the prescriptions contain a plant-derived compound. Morphine, quinine, digitalin, ephedrine and reserpine, for example, were isolated from traditional medicinal plants, which were known to be efficacious in the treatment of certain diseases long before phytochemical and pharmacological investigations. For thousands of years, traditional medicine and remedies have been practiced and used in China. They have proved to be valuable and the essence of vast historical experience. The Chinese people believe that traditional medicine is consistent with their own culture and continues to play a crucial role in helping the Chinese nation flourish. However, in the Western scientific community the study and use of ethnic or traditional drugs have been virtually ignored for decades. The new methods and techniques for new drug design and modern biotechnology were supposed to have led into the age of rational drug design, in which drugs would be formulated by means of scientific principles and computer aided design, doing away with the need to rely on natural sources. A number of pharmaceutical companies and research institutions now realize that synthetic drugs cannot always duplicate the curative effects of natural products, and new drug design methods and techniques cannot always provide the totally novel bioactive molecules which exist in nature. No matter how important and potential the rational drug design is for the future drug development, it has so far proved difficult to design novel molecules completely from scratch. Millions of years of plant evolution have led to the development of many secondary metabolites with various and unique chemical structures, that mankind has not even thought of.
